Skip to main content

InvestorNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Retains Litigation Firm to Investigate Frivolous Claims, Unauthorized Tagging of Its Stock

Jupiter Wellness (NASDAQ: JUPW), a diversified company that supports health and wellness, announced that it has retained Gusrae, Kaplan, Nusbaum PLLC as its securities litigation firm to investigate frivolous claims, allegations and the unauthorized tagging of its stock by FSD Pharma on Aug. 25, 2023. Jupiter Wellness acquired the asset Safety Shot from GBB Drink Lab who in May 2023 filed a $53 million dollar lawsuit against FSD Pharma. Jupiter Wellness is not a party to such action. “We do not comment on frivolous claims or pending litigation, however, be assured we will use every remedy under the law to protect Jupiter Wellness and its shareholders against these purposeful violations and attempts to harm Jupiter Wellness and its shareholders,” said Jupiter Wellness CEO Brian John. “We look forward to the outcome of GBB’s lawsuit being settled in a court of law.”

To view the full press release, visit https://ibn.fm/FXMgk

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, psoriasis and vitiligo. Revenue is generated through the sales of OTC and consumer products and licensing royalties. Interested investors and shareholders are encouraged to sign up for press releases and industry updates by registering for email alerts at JupiterWellness.com/email-alerts and by following Jupiter Wellness on Twitter and LinkedIn.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.